2021年10月1日简报:新冠疫情致欧美多国人口预期寿命缩短;新冠疫情将进入新常态,年底可能会上市多种新冠病毒口服治疗药物;仅15个非洲国家完成了10%的新冠疫苗接种阶段目标

2021-10-01 MedSci整理 MedSci整理

截至北京时间2021年10月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过23451万例,新增474,237例,达到234,514,13

截至北京时间2021年10月1日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过23451万例,新增474,237例,达到234,514,130例。累计死亡病例479.6万例,达到4,796,134例。新增死亡为7,539例。康复为211,309,294例,重症和危重症病人达到88,961例;全球新冠确诊病例超过100万例的国家达35个,109个国家病例超10万例。昨日报道:2021年9月30日简报:天津全面开始接种加强针,儿童接种新冠疫苗正在争议,吸烟者感染新冠概率比普通人高80%,全球康复超过2.1亿人

 

新冠疫情致欧美多国人口预期寿命缩短 美国降幅最大

英国牛津大学日前发表的一份研究显示,受新冠疫情影响,2020年欧美多国人口出生时预期寿命缩短,降幅为第二次世界大战以来最大,而这些国家中又以美国人口预期寿命降幅最大。

由牛津大学和南丹麦大学科研人员组成的研究小组收集了29个国家的人口统计数据、2020年官方死亡人员登记数据和死亡率等,涵盖欧洲多国以及美国、智利等,并结合2015年至2019年的相关数据进行分析。

这项发表在新一期英国《国际流行病学杂志》上的研究结果显示,从2015年到2019年,所有国家人口出生时预期寿命均有所增加。而在2020年,29个国家中有27个人口出生时预期寿命缩短,其中22个国家缩短6个月以上,8个国家的女性和11个国家的男性出生时预期寿命缩短1年以上。

研究还显示,大多数国家男性的预期寿命降幅大于女性。其中,美国男性的预期寿命降幅最大,与2019年相比缩短2.2岁;美国女性的预期寿命降幅也超过1.5岁。

研究人员表示,西班牙、英国、意大利、比利时等国上一次人口出生时预期寿命在一年内出现如此大的降幅是在二战期间。

世卫组织:仅15个非洲国家完成了10%的新冠疫苗接种阶段目标

当地时间9月30日,世卫组织非洲区域办事处在刚果(布)首都布拉柴维尔召开在线记者会。根据发布会的内容,截至9月底,仅有15个非洲国家完成了为10%的国民完成新冠疫苗接种的目标,而在年底前为40%的非洲人口全面接种疫苗的目标恐难以实现。

根据世卫组织非洲区域免疫和疫苗开发项目负责人理查德·米希果的介绍,今年5月,世界卫生大会制定了到9月30日前为各国10%的人口全面接种新冠疫苗的全球目标。近90%的富裕国家已经实现了这一目标。而在非洲,由于疫苗交付缓慢,只有6000多万非洲人完全接种了疫苗,且主要来自人口较少的国家,如塞舌尔和毛里求斯等岛国。

美国俄亥俄州儿童新冠住院病例激增 医疗系统超负荷运转

据美国广播公司(ABC)当地时间9月30日报道,俄亥俄州儿童新冠感染率处于极高水平,儿童住院病例不断激增,医疗系统超负荷运转。

俄亥俄州卫生专家表示,截至9月29日,该州有超过210名儿童新冠住院病例,总数位居全美第二,儿童感染现象已处于临界水平。 俄亥俄州代顿儿童医院(Dayton Children's Hospital)工作人员则表示,受到德尔塔变异毒株影响,感染新冠的儿童病例数不断激增,在该医院治疗的病例人数已经刷新历史纪录,数值出现了“天文数字般的增长”。

由于儿童感染率不断升高,俄亥俄州6家儿童医院曾在9月早些时候与俄亥俄州儿童医院联合发布警告称,该州儿童新冠感染现象已经对儿科医疗系统产生威胁。报告显示,染病儿童的病情不断加重,其中很多人需要使用呼吸机。

俄罗斯疫情出现反弹 各地收紧防疫措施

9月30日,俄罗斯副总理戈利科娃对媒体表示,俄罗斯目前正在经历一个疫情反弹上升期,她告诫民众遵守防疫规定,保护好自己和家人。据统计,目前俄罗斯85个联邦主体当中有56个出现疫情反弹。俄罗斯总理米舒斯京当天表示,俄罗斯的疫情形势非常严峻,最近两周住院人数增加了25%,每日新增死亡人数连续3天创下新高。

截至9月29日,已经有多个州宣布收紧防疫措施。彼尔姆边疆区、乌德穆尔特共和国、乌里扬诺夫斯克州等地要求从10月初开始在公共场所使用QR码(一种二维码),萨马拉、萨拉托夫、库尔斯克等州宣布近期停止举行大型文体、娱乐活动。莫斯科则要求,从10月1日起所有出现急性病毒性呼吸道感染症状的患者都必须进行新冠病毒抗原快速检测。

德国关闭大部分疫苗接种中心 疫苗接种将更分散更具流动性

德国大部分疫苗接种中心将于当地时间9月30日关闭。从10月1日起,该国的疫苗接种将以更加分散和更具流动性的方式进行。

对此,德国社会协会呼吁为社会弱势群体提供更多的疫苗接种服务。该协会主席本特勒表示:“我们需要更多的流动疫苗接种服务,特别是对于社会弱势群体和无家可归者而言,在步行街、超市停车场、运动场、就业中心前等场所提供接种服务非常必要。”疫苗接种中心的关闭意味着接种服务的减少,本特勒要求更主动地为民众提供接种服务。

德国在6月份的卫生部长会议上决定从9月30日起关闭大部分的疫苗接种中心,但各联邦州应确保短时间内可以恢复疫苗接种能力。

新加坡“与新冠共处”战略遭考验

新加坡的“与新冠病毒共处”战略正受到每日新增病例创纪录增长的考验。这凸显了新冠肺炎从大流行病向流行病转变所带来的挑战。但新加坡卫生官员称,新增病例激增是回归正常道路“必须经历的一段过程”。目前,新加坡是世界上新冠疫苗接种率最高的国家之一,接种率达到82%。

报道称,到目前为止,新加坡政府尚未重新实施全面封锁措施,但已暂停进一步重新开放措施,同时对感染率迅速上升感到担忧。为了确保医疗系统能够应对不断攀升的新增病例数量,当局最近采取了加强保持社交距离的措施。

BioNTech高管:新冠疫情将进入新常态

与辉瑞公司合作共同开发新冠疫苗的德国生物技术公司BioNTech联合创始人兼首席医学官厄兹勒姆·图雷西(Ozlem Tureci)告诉媒体,“新冠疫情未来将变得可控,世界不应该深陷在这种病毒的恐惧中。”

图雷西于2008年和其丈夫吴沙忻(Ugur Sahin)在德国美因茨联合创立了开发免疫治疗癌症药物的BioNTech。2018年8月,BioNTech宣布与美国辉瑞公司展开合作研究,开发基于mRNA的疫苗。

“未来将出现更多病毒变种,BioNTech将密切关注不断评估。”图雷西强调,“这种病毒仍将伴随我们若干年,所以我们需要进入到一个新的常态。”

“我们必须继续进行新冠筛查,以防新的变体出现。我们需要在适应一种病毒变体的时候,快速为下一个潜在变体做准备。”图雷西告诉媒体,“我们正在与监管机构一起推进模拟试验,以便他们为突发情况做好准备。”

对于目前肆虐全球的新冠病毒德尔塔变种,她认为,只需要靠疫苗增强剂(第三针)就能使减弱的免疫反应恢复到较高水平。“(第三针)是合适的,能起到保护作用。”

图雷西说,走出大流行的道路需要更多的数据指引。她表示,“存在一种可能性,未来每隔12个月或每隔18个月都需要接种一次新冠疫苗加强剂。”

三种口服抗新冠病毒药物临床试验结果将于年底发布,有望应用于早期治疗 

美国国家过敏和传染病研究所艾滋病司司长Carl Dieffenbach接受采访时表明,至少有三种颇具希望的抗新冠病毒药物正在进行临床试验,预计最早会在今年秋末或冬季公布结果。

Dieffenbach 说,默沙东和 Ridgeback Biotherapeutics所开发的Molnupiravir是当前竞争力最强的候选药物,另外两种是辉瑞的PF-07321332以及罗氏和Atea开发的AT-527,它们可以干扰新冠病毒在人体当中的复制过程。以Molnupiravir为例,它作用于病毒遗传物质复制酶,使其无法繁殖,从而达到降低患者体内病毒载量,减少感染时间,避免重症死亡风险的作用。

本土疫情情况

2021年9月29日0-24时,黑龙江省新增新冠肺炎本土确诊病例6例(哈尔滨市南岗区1例、巴彦县5例);新增治愈出院境外输入确诊病例2例。

以色列疫情被遏制

当地时间9月30日晚,以色列卫生部发布的新冠肺炎疫情最新数据显示,9月29日18时至30日18时,以色列新增新冠肺炎确诊病例4506例,累计确诊病例1281776例;新增死亡病例29例,累计死亡病例7761例。该国现存新冠肺炎确诊病例46503例,现存重症病例619例,其中211人需要使用呼吸机。重症中超过半数未接种疫苗。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-10-01 13f0c37dm61暂无昵称

    谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-10-01 ms9000000677789757

    写的很好

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1921849, encodeId=d1de1921849cf, content=<a href='/topic/show?id=4f0a6469837' target=_blank style='color:#2F92EE;'>#治疗药物#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64698, encryptionId=4f0a6469837, topicName=治疗药物)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c9d3459, createdName=周虎, createdTime=Sat Nov 13 12:50:42 CST 2021, time=2021-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1661438, encodeId=065d16614384c, content=<a href='/topic/show?id=017899514a0' target=_blank style='color:#2F92EE;'>#非洲国家#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99514, encryptionId=017899514a0, topicName=非洲国家)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sat Aug 20 03:50:42 CST 2022, time=2022-08-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1258101, encodeId=239b1258101e1, content=<a href='/topic/show?id=f538e0501e9' target=_blank style='color:#2F92EE;'>#疫苗接种#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70501, encryptionId=f538e0501e9, topicName=疫苗接种)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5c0050, createdName=lishiwen, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315887, encodeId=1a15131588e8a, content=<a href='/topic/show?id=bbc8100216a0' target=_blank style='color:#2F92EE;'>#预期寿命#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100216, encryptionId=bbc8100216a0, topicName=预期寿命)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ba58436, createdName=马龙, createdTime=Sat Oct 02 22:50:42 CST 2021, time=2021-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056760, encodeId=060c1056e600b, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Fri Oct 01 14:13:20 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056720, encodeId=6af01056e20b6, content=写的很好, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1d435617075, createdName=ms9000000677789757, createdTime=Fri Oct 01 10:01:50 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056713, encodeId=3adb1056e13f2, content=新冠疫情防控常态化。, beContent=null, objectType=article, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJlfgys76DEiaNtbYo2re3ibjrUPTRibEXRyFwAB4aAGiave842S0FQDf0wAoaH226NiaSoPPDzhndsf1g/132, createdBy=88b489038, createdName=yangchou, createdTime=Fri Oct 01 09:11:52 CST 2021, time=2021-10-01, status=1, ipAttribution=)]
    2021-10-01 yangchou

    新冠疫情防控常态化。

    0

相关资讯

张文宏凌晨发长文解读南京疫情,关键在于后续1-2周的监测

近期南京疫情跨省传播,成为大家最关心的话题之一。

新冠战争已彻底改变,先不要急着说“与病毒长期共存”!

近期美国CDC文件显示Delta突变株具有超强的传染性!即使对已完成疫苗接种的人来说,当感染了Delta变异株时,与没有接种疫苗的感染者相比,体内仍会产生相同数量的病毒,且传染力相差无几。

新冠变异毒株“德尔塔”持续扩散,南京何以几近封城?

江苏正遭遇过去一年来最严重的本土疫情。

2021年8月7日简报:全国多地实行全员核酸检测,筛选感染人群;美国2008年就成功合成新型冠状病毒;Lambda毒株可能是delta毒株后的新王者

截至北京时间2021年8月7日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过20235万例,新增689,707例,达到202,352,487

2021年7月6日全球新冠肺炎疫情及疫苗接种简报:中国接种新冠疫苗超13亿剂,全球因新冠死亡人数超400万人

截至北京时间2021年7月6日7时31分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过18490万例,新增332,406例,达到184,908,341

此轮南京疫情涉及2省4地,42人感染,你如何看?

7月22日0-24时,江苏新增本土确诊病例12例和7例本土无症状感染者。其中,南京当日新增本土确诊病例12例(其中5例轻型,7例普通型),新增无症状感染者6例,多数为禄口国际机场工作人员。此外,江苏省